The history of Sildenafil presents a nuanced case for stakeholders in the pharmaceutical sector. While initially a blockbuster success, producing vast sums, the intellectual property lapse and the subsequent flood of cheaper competitors have significantly changed revenue. This poses questions about the future sustainability of similar therapeuti… Read More